These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 22542728

  • 21. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.
    Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T.
    Acta Oncol; 2014 Jan; 53(1):143-8. PubMed ID: 23710697
    [No Abstract] [Full Text] [Related]

  • 22. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW.
    BMC Cancer; 2011 Jun 24; 11():266. PubMed ID: 21702914
    [Abstract] [Full Text] [Related]

  • 23. FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
    Malle P, Sorschag M, Gallowitsch HJ.
    Wien Med Wochenschr; 2012 Oct 24; 162(19-20):423-9. PubMed ID: 22890522
    [Abstract] [Full Text] [Related]

  • 24. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.
    Yanagawa S, Tanabe K, Suzuki T, Tokumoto N, Arihiro K, Ohdan H.
    World J Surg Oncol; 2014 Feb 27; 12():47. PubMed ID: 24575748
    [Abstract] [Full Text] [Related]

  • 25. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D, Pereira-Pérez F, Castaño-Pascual A, Durán-Poveda M, Antequera-Pérez A, Miliani-Molina C.
    Cir Cir; 2012 Feb 27; 80(1):44-51. PubMed ID: 22472152
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
    Pantaleo MA, Nicoletti G, Nanni C, Gnocchi C, Landuzzi L, Quarta C, Boschi S, Nannini M, Di Battista M, Castellucci P, Fanti S, Lollini PL, Bellan E, Castelli M, Rubello D, Biasco G.
    J Exp Clin Cancer Res; 2010 Dec 30; 29(1):173. PubMed ID: 21192792
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate.
    Goh BK, Chow PK, Chuah KL, Yap WM, Wong WK.
    Eur J Surg Oncol; 2006 Nov 30; 32(9):961-3. PubMed ID: 16842963
    [Abstract] [Full Text] [Related]

  • 38. Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib.
    Shinto A, Nair N, Dutt A, Baghel NS.
    Clin Nucl Med; 2008 Jul 30; 33(7):486-7. PubMed ID: 18580237
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.